Lipid-Lowering Therapy for the Primary Prevention of Cardiovascular Disease in the Elderly: Opportunities and Challenges

Author： Robinson Jennifer G.  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.26, Iss.11, 2009-11, pp. : 917-931

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial:primary Prevention of Coronary Heart Disease with Lipid Lowering Therapy

By Bernini F.   Paoletti R.  

Pharmacological Research, Vol. 35, Iss. 3, 1997-03 ,pp. : 167-167

Academic Press

Access to resources Recommend Favorite

Primary prevention strategies for lipid-lowering: cost effectiveness

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 575, 2009-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Lipid-lowering Drug Therapy in Elderly Patients

By  

Current Pharmaceutical Design, Vol. 17, Iss. 9, 2011-03 ,pp. : 877-893

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics of apolipoprotein E gene during lipid-lowering therapy: lipid levels and prevention of coronary heart disease

By Nieminen Tuomo   Käähöönen Mika   Viiri Leena E   Gröönroos Paula   Lehtimääki Terho  

Pharmacogenomics, Vol. 9, Iss. 10, 2008-10 ,pp. : 1475-1486

Future Medicine

Access to resources Recommend Favorite

Lipid-lowering therapy in diabetes

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 342, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite